These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 37491648

  • 1. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma.
    Wong CE, Liao WA, Chang Y, Lee PH, Huang CC, Chang KC, Lee JS.
    Clin Exp Med; 2023 Nov; 23(7):3799-3807. PubMed ID: 37491648
    [Abstract] [Full Text] [Related]

  • 2. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
    Wu S, Wang J, Liu W, Hu F, Zhao K, Jiang W, Lei T, Shu K.
    BMC Neurol; 2021 May 11; 21(1):190. PubMed ID: 33975554
    [Abstract] [Full Text] [Related]

  • 3. Whether surgical resection or biopsy makes difference in single lesion primary central nervous system lymphoma: a single center retrospective cohort study.
    Cheng X, Chen H, Sun C, Zhang B, Zhang J, Wang Y.
    BMC Neurol; 2022 Nov 05; 22(1):411. PubMed ID: 36333683
    [Abstract] [Full Text] [Related]

  • 4. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
    Ouyang T, Wang L, Zhang N, Zhang Z, Xiong Y, Li M, Hong T.
    World Neurosurg; 2020 Jul 05; 139():e508-e516. PubMed ID: 32311566
    [Abstract] [Full Text] [Related]

  • 5. C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients.
    Zuo J, Lei T, Zhong S, Zhou J, Liu R, Wu C, Li S.
    Neurosurg Rev; 2023 Dec 19; 47(1):17. PubMed ID: 38112846
    [Abstract] [Full Text] [Related]

  • 6. PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma.
    Furuse M, Kuwabara H, Ikeda N, Hattori Y, Ichikawa T, Kagawa N, Kikuta K, Tamai S, Nakada M, Wakabayashi T, Wanibuchi M, Kuroiwa T, Hirose Y, Miyatake SI.
    BMC Cancer; 2020 Apr 05; 20(1):277. PubMed ID: 32248797
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma.
    Song MK, Chung JS, Joo YD, Lee SM, Oh SY, Shin DH, Yun EY, Kim SG, Seol YM, Shin HJ, Choi YJ, Cho GJ.
    J Neurooncol; 2011 Sep 05; 104(3):825-31. PubMed ID: 21380743
    [Abstract] [Full Text] [Related]

  • 9. Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma.
    Cho I, Lee H, Yoon SE, Ryu KJ, Ko YH, Kim WS, Kim SJ.
    BMC Cancer; 2020 Feb 13; 20(1):120. PubMed ID: 32054467
    [Abstract] [Full Text] [Related]

  • 10. Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients.
    Fudaba H, Momii Y, Hirakawa T, Onishi K, Asou D, Matsushita W, Kawasaki Y, Sugita K, Fujiki M.
    Sci Rep; 2021 Jan 13; 11(1):1206. PubMed ID: 33441719
    [Abstract] [Full Text] [Related]

  • 11. Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma.
    Kreher S, Jöhrens K, Strehlow F, Martus P, Borowiec K, Radke J, Heppner F, Roth P, Thiel E, Pietsch T, Weller M, Korfel A.
    Neuro Oncol; 2015 Jul 13; 17(7):1016-21. PubMed ID: 25817328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin.
    Lin CH, Kuo KT, Chuang SS, Kuo SH, Chang JH, Chang KC, Hsu HC, Tien HF, Cheng AL.
    Clin Cancer Res; 2006 Feb 15; 12(4):1152-6. PubMed ID: 16489068
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.
    Sun X, Wang C, Chen C, Huang J, Wu X, Wang Y, He X, Cao J, Jiang W, Sun P, Li Z.
    Hematol Oncol; 2021 Dec 15; 39(5):625-638. PubMed ID: 34543472
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.